Arterial thromboembolism in patients with sick sinus syndrome: Prediction from pacing mode, atrial fibrillation, and echocardiographic findings

Heart

Volumn 81, Issue 4, 1999, Pages 412-418

  Andersen, H R ^a   Nielsen, J C ^a   Thomsen, P E B ^a   Thuesen, L ^a   Pedersen, A K ^a   Mortensen, P T ^a   Vesterlund, T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Atrial fibrillation; Atrial pacing; Sick sinus syndrome; Thromboembolism

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SICK SINUS SYNDROME; THROMBOEMBOLISM;

EID: 0032896811     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.4.412     Document Type: Article

References (38)

1. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow up of patients from a randomised trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997;350:1210-16.
2. Nielsen JC, Andersen HR, Thomsen PE, et al. Heart failure and echocardiographic changes during long term follow up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation 1998;97:987-95.
3. Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523-8.
4. Rubenstein JJ, Schulman CL, Yurchak PM, et al. Clinical spectrum of the sick sinus syndrome. Circulation 1972;46:5-13.
5. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
6. Sgarbossa EB, Pinski SL, Maloney JD, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 1993;88:1045-53.
7. Stangl K, Seitz K, Wirtzfeld A, et al. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. PACE 1990;13:2080-5.
8. Brandt J, Anderson H, Fahraeus T, et al. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J Am Coll Cardiol 1992;20:633-9.
9. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988;116:16-22.
10. Santini M, Alexidou G, Ansalone G, et al. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol 1990;65:729-35.
11. Sasaki Y, Shimotori M, Akahane K, et al. Long-term follow up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. PACE 1988;11:1575-83.
12. Fairfax AJ, Lambert CD, Leatham A. Systemic embolism in chronic sinoatrial disorder. N Engl J Med 1976;295:190-2.
13. Santini M, Ansalone G, Auriti A. Sick sinus syndrome: natural history before and after pacing. Eur J Card Physiol Electrophysiol 1993;3:220-31.
14. Sutton R, Kenny RA. The natural history of sick sinus syndrome. PACE 1986;9:1110-14.
15. Fisher M, Kase CS, Stelle B, et al. Ischemic stroke after cardiac pacemaker implantation in sick sinus syndrome. Stroke 1988;19:712-15.
16. Santini M, Ansalone G, Auriti A, et al. Stroke in sinus node disease. In: Rosenqvist M, ed. Cardiac pacing: new advances. London: WB Saunders Co, 1997:101-19.
17. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
18. Sethi KK, Bajaj JC, Mohan JC, et al. Comparison of atrial and VVI pacing modes in symptomatic sinus node dysfunction without associated tachyarrhythmias. Indian Heart J 1990;42:143-7.
19. Sasaki S, Takeuchi A, Ohzeki M, et al. Long-term follow up of paced patients with sick sinus syndrome. In: Steinbach K, Glokar D, Laszkovics A, et al, eds. Cardiac pacing. Proceedings of the VIIth world symposium on cardiac pacing. Darmstadt: Steinkopff Verlag, 1983:85-90.
20. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: 1. Clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
21. Cabin HS, Clubb KS, Hall C, et al. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990;65:1112-16.
22. Benjamin EJ, D'Agostino RB, Belanger AJ, et al. Left atrial size and the risk of stroke and death. The Framingham heart study. Circulation 1995;92:835-41.
23. Fazio S, Cittadini A, Sabatini D, et al. Platelet aggregability in patients with a VVI pacemaker. PACE 1993;16:254-6.
24. Lau CP, Tse H, Cheng G. Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients. Heart 1997;78:358-63.
25. Simantirakis EN, Parthenakis FI, Chrysostomakis SI, et al. Left atrial appendage function during DDD and VVI pacing. Heart 1997;77:428-31.
26. Lee T-M, Su S-F, Chien K-L, et al. Left atrial spontaneous echo contrast in patients with permanent pacemakers. Heart 1997;78:262-7.
27. Fazio S, Santomauro M, Cittadini A, et al. Efficacy of ticlopidine in the prevention of thromboembolic events in patients with WI pacemakers. PACE 1991;14:168-73.
28. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11.
29. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Final results. Circulation 1991;84:527-39.
30. Roy D, Marchand E, Gagne P, et al. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J 1986;112:1039-43.
31. Orsinelli DA. Current recommendations for the anticoagulation of patients with atrial fibrillation. Prog Cardiovasc Dis 1996;39:1-20.
32. Munschauer FE, Priore RL, Hens M, et al. Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. Stroke 1997;28:72-6.
33. Lip GY, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J 1994;71:92-5.
34. Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med 1996;11:713-20.
35. Whittle J, Wickenheiser L, Venditti LN. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 1997;157:441-5.
36. Goldstein LB, Farmer A, Matchar DB. Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom. Stroke 1997;28:746-51.
37. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987;147:1561-4.
38. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989;i:175-9.